Our partner Signos has received clearance from the U.S. Food and Drug Administration for its over-the-counter Glucose Monitoring System designed to support weight management. The system combines the Stelo by Dexcom glucose biosensor with Signos’ AI-driven platform to provide real-time insights on how food, activity, stress, and sleep impact the body.
By translating glucose fluctuations into simple, personalized recommendations, Signos empowers users to improve daily habits, better manage weight, and lower chronic disease risk. This milestone highlights Signos’ mission to make personalized, biology-backed health guidance more accessible.